Last reviewed · How we verify
NCT05338996
Addressing Health Disparities in Engagement, Retention, and Utilization of PrEP Among South Florida Women of Color
NA trial testing iENGAGE for PrEP in HIV Prevention in 72 participants. Completed in 31 May 2023.
31 May 2023
Quick facts
| Lead sponsor | Florida International University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 72 |
| Start date | 1 October 2021 |
| Primary completion | 31 May 2023 |
| Estimated completion | 31 May 2023 |
| Sites | 3 locations across United States |
Drugs / interventions tested
- iENGAGE for PrEP
Conditions studied
- HIV Prevention — all drugs for HIV Prevention →
- PrEP Adherence — all drugs for PrEP Adherence →
Sponsor
Florida International University
Who can join
18 and older, female only, with HIV Prevention or PrEP Adherence. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Women of color (WOC) in South Florida, the region with the highest HIV rates in the U.S., experience significant barriers to accessibility, uptake, and utilization of Pre-exposure prophylaxis (PrEP) for HIV prevention, despite FDA approval since 2012. The purpose of this study is to use a Community-Based Participatory Research (CBPR) approach to finalize, and pilot-test a multi-component evidence-based intervention to reduce health disparities in engagement, utilization, and retention in PrEP care, with the goal of improving HIV prevention outcomes for the target population of WOC in S. Florida, primarily African American, Latina, and Haitian women in 3 designated Ending the HIV Epidemic (EHE) counties: Miami-Dade, Broward, and Palm Beach counties.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05338996
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for HIV Prevention
Currently open trials in the same condition.
- NCT07194902 — HIV Self-testing for Partners of HIV-uninfected Postpartum Women · NA · recruiting
- NCT07218211 — Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP · Phase 4 · recruiting
- NCT07349758 — Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers · Phase 1 · recruiting
- NCT07433985 — California MEPS Hub · NA · recruiting
- NCT07002866 — Suubi4PrEP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda · NA · recruiting
Other Florida International University trials
Trials by the same sponsor.
- NCT06965712 — Use of Point-of-Care Ultrasound (POCUS) to Reduce Hospital Length of Stay in Patients With Heart Failure ( POCUSHF ) · NA · recruiting
- NCT06489314 — Mental Health Treatment to Improve Father Depression and Child Outcomes in Kenya · NA · enrolling by invitation
- NCT07199361 — Uncovering the Mechanism of Pain Relief by Peripheral Transcutaneous Magnetic Stimulation · NA · recruiting
- NCT04571502 — Integration of Health Information Technology and Promotion of Personhood in Family-Centered Dementia Care · NA · enrolling by invitation
- NCT06637436 — PrEP Readiness Interventions for Sustained Motivation (PRISM) · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05338996 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Florida International University
- Last refreshed: 27 June 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05338996.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing